A Long-Term Single-Center Registry of 6893 Patients Undergoing Elective Percutaneous Coronary Intervention With the Xience Everolimus-Eluting Stent

Journal of Invasive Cardiology

28 January Jan 2019 7 years ago
  • Trabattoni D, Fabbiocchi F, Montorsi P, Galli S, Ravagnani P, Calligaris G, Teruzzi G, Grancini L, Troiano S, Ferrari C, Bartorelli AL
QR Code

This large, prospective registry confirms the very long-term safety and efficacy of the everolimus-eluting stent (EES) in unselected real-world and complex coronary lesions.

Reference

Trabattoni D, Fabbiocchi F, Montorsi P, Galli S, Ravagnani P, Calligaris G, Teruzzi G, Grancini L, Troiano S, Ferrari C, Bartorelli AL. A Long-Term Single-Center Registry of 6893 Patients Undergoing Elective Percutaneous Coronary Intervention With the Xience Everolimus-Eluting Stent. J Invasive Cardiol 2019 Jan 15. pii: JIC2019115-3. [Epub ahead of print]

Go to PubMed